Sources & reporting

Why Your State, Not D.C., Should Be Making This Call

The American Take separates sourced factual reporting from analysis and commentary. These links let readers inspect the reporting that informed this article.

• Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court (timeline) — KFF ↗
• Fifth Circuit questions Louisiana's renewed attempt to block abortion pill mailing — Courthouse News ↗
• Supreme Court Stays Fifth Circuit Order Banning Telehealth Prescribing and Mail Dispensing of Mifepristone — Goodwin Law ↗
• Supreme Court preserves telehealth access to abortion pill mifepristone pending appeal — Jurist ↗
• Republican AGs sue abortion 'shield law' states in U.S. Supreme Court — Stateline ↗
• Louisiana Leads Supreme Court Challenge to Abortion Pill Shield Laws — Hoodline ↗
• FDA Lawyer Leaves Door Wide Open for Mifepristone Restrictions at Appeals Court Hearing — Autonomy News ↗
• Federal Appeals Court Weighs New Challenge to Abortion Pill Access by Mail — Law Commentary ↗
• The Federal Mifepristone Safety Review Is Still Unfinished While Senators Press Its Three Approved Manufacturers on Oversight — Medical Daily ↗